Weed, nasal flu vaccine and earnings

Today’s big movers inside                                                                                                                                                                                                                                                                                                                                                                                                                 May 01, 2024 | [Read Online]( Weed, nasal flu vaccine and earnings *together with Katusa Research Good morning, 360! TONIGHT at 8pm EST in the [Market Master’s Room](, Jason Bond will be hosting a special presentation geared to 9-5ers about how to manage trading in his Small Account Journey. Set a reminder ⏰ FOCUS LIST🔎 POAI - Up over 30% in pre after announcing a collaboration with FluGen in the development of a first-of-its-kind intranasal flu vaccine to market IMCC - Weed related name, up over 40% in the pre-market after yesterday US DEA announced it will reclassify marijuana, ease restrictions PINS - Up over 15% in pre after crushing earnings estimates  *together with Katusa Research The Most Important Gold Broadcast of 2024 Marin Katusa has just unleashed a MAJOR gold broadcast. If you’re interested or invested in gold and gold stocks, we urge you to watch. And in this emergency briefing, he details exactly what’s happening right now in the precious metals markets. With a specific focus on gold. Is gold going higher? Are commodities starting their long-awaited breakout to much higher levels? Marin will go over everything in his [emergency briefing](, including: - Why Gold is rising in the East and setting in the West (for now), and when they’ll rise together - 8 flashing signals that show why gold is set to soar higher - A HUGE secret of the gold market the mainstream financial media has no idea about (Hint: these are the gold stocks you must avoid buying at all costs)… - The best gold stocks to begin accumulating right now [Click here to watch the interview right now.]( Be prepared for the next inning of this cycle! *We are a proud affiliate for Katusa, see disclosures below. HOTLIST🔥 POAI - Up over 30% in pre after announcing a collaboration with FluGen in the development of a first-of-its-kind intranasal flu vaccine to market Predictive Oncology (POAI) is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. In the after-hours yesterday, the [company announced]( a collaboration with FluGen to bring a first-of-its-kind intranasal flu vaccine to market, as part of a $6.2 million Phase 2B grant awarded by the United States Department of Defense (DoD). Paul Radspinner, President & Chief Executive Officer of FluGen stated: “Predictive Oncology will play a critical role in helping to make our M2SR flu vaccine more stable and sustainable as we advance our clinical trials” POAI had a market cap of less than $6million according to Finviz based on yesterday’s close. The stock traded up over 30% in the pre-market after the news yesterday. The $1.80 area acted as support in the after-hours and the pre-market and now becomes a potential level of resistance. Above it, targets to the upside are $1.95, $2 and then the after-hours high at $2.10. Beyond that $2.34 and $2.50 come into play. Below $1.80, targets to the downside are $1.73, $1.60, $1.50, and then a gap fill at $1.41. IMCC - Weed related name, up over 40% in the pre-market after yesterday US DEA announced it will reclassify marijuana, ease restrictions IM Cannabis Corp. (IMCC) engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. Intraday yesterday, the US DEA [announced]( that it will reclassify marijuana as a less dangerous drug. The proposal, which still must be reviewed by the White House Office of Management and Budget, would recognize the medical uses of cannabis and acknowledge it has less potential for abuse than some of the nation’s most dangerous drugs. However, it would not legalize marijuana outright for recreational use. “Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” Justice Department director of public affairs Xochitl Hinojosa said in a statement. The news sent weed stocks soaring intraday yesterday with IMCC closing up 55% pulling back after being up over 100%. Perhaps the international nature of IMCC (based in Israel and Germany) had some short sellers stuck in the after hours, as the stock is up another 40% this morning. The $1.20 area was resistance yesterday intraday and has since acted as support in the after-hours and pre-market. Above it, targets to the upside are $1.36, $1.50 and then the after-hours high at $1.62. Beyond that, $1.83 and $2 and $2.14 come into play. Below $1.20, targets to the downside are $1, $0.86, $0.80 and then $0.60. [Learn How to Fish in Small Account Journey](  Join Jason Bond as he teaches [his favorite strategy]( to pursue his mission of turning $2000 into $100,000.  SPECIAL ENDS THURSDAY [Live Webinar Tonight at 8pm EST in THIS ROOM]( PINS - Up over 15% in pre after crushing earnings estimates Pinterest, Inc. (PINS) operates as a visual search and discovery platform in the United States and internationally. Its platform allows people to find ideas, such as recipes, home and style inspiration, and others; and to search, save, and shop the ideas. In the after-hours yesterday, the [company reported]( Q1 2024 earnings that topped estimates on both the top and bottom line. PINS reported Q1 adjusted earnings of $0.20 per share versus a $0.14 estimate. Q1 revenue of $740.0 million was better than the $700.3 million estimate. PINS reported having 518 million monthly active users compared to an estimated 503.75 million. Average revenue per user of $1.46 topped estimates of $1.39. The stock traded up over 15% in the pre-market in reaction to the earnings beat. $38.31 acted as a support area in the pre-market and will be an important level to watch. Above it, targets to the upside are $39.30, $39.50 and $39.90 and then the after-hours high at $41.65. Beyond that, $45 and $48 come into play. Below $38.31, targets to the downside are $36, $35 and then a gap fill at $33.45. MARKET NEWS 📰 MORE Great Trading Resources: [Get instant access to Jeff Bishop's top trading ideas]( [For great training in options basics, start your journey Jeff Williams]( Questions or concerns about our products? Email Support@360wallstreet.io © Copyright 2022, RagingBull DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at . *Sponsored content: We’re a proud affiliate for Katusa Research, meaning if you click a link for a product or service, we may earn a commission at no extra cost to you. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers mentioned in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. [tw]( Update your email preferences or unsubscribe [here]( © 2024 360 WallStreet 62 Calef Hwy. #233 lee, NH 03861, United States of America